Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/23/25 17:00 | 5/21/25 | IDXX | BizSv | Paper | Manifold Business Forms | Szostak M Anne | ME | D | 3 | S.d | -2,815 | 484.92 | 0 | -6 | 6 | M | ||||||||||||||||
5/14/25 17:00 | 5/13/25 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Junius Daniel M | ME | D | 1 | S.d | -1,359 | 506.41 | 0 | -3 | 3 | D | ||||||||||||||||
5/13/25 17:00 | 5/9/25 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Vandebroek Sophie V. | ME | D | 3 | S.d | -1,563 | 516.51 | 0 | -3 | 9 | D | ||||||||||||||||
2/11/25 17:00 | 2/10/25 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Fennell George | ME | O | EVP | 1 | S.d | -4,619 | 462.53 | 0 | -10 | 8 | D | |||||||||||||||
5/20/24 17:00 | 5/17/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Claflin Bruce L. | ME | D | 1 | S | -108 | 540.80 | 0 | 0 | 2 | D | ||||||||||||||||
3/7/24 17:00 | 3/6/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Polewaczyk James F | ME | O | EVP | 1 | S.d | -4,526 | 558.44 | 0 | -8 | 11 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |